VOV.VN - The Ministry of Health has permitted the Institute of Vaccines and Medical Biologicals (IVAC) to carry out clinical human trials of its produced vaccine COVIVAC, starting in a couple of weeks.

VOV.VN - The country is poised to get the second part of human trials for the COVIVAX novel coronavirus (COVID-19) vaccine underway in early January, with the vaccine notable for being developed locally by the Institute of Vaccines and Medical Biologicals (IVAC).

VOV.VN -The Ministry of Health has granted permission to the Nha Trang-based Institute of Vaccines and Biological Medical (IVAC) to carry out human clinical tests for Covivac, a locally-produced novel coronavirus (COVID-19) vaccine, on volunteers in January, two months ahead of schedule.

VOV.VN - Three local volunteers were given a 50mcg dose of the Made-in-Vietnam novel coronavirus (COVID-19) vaccine Nano Covax on December 26 at the Hanoi-based Military Medical Academy.

VOV.VN - Vietnam has raised concerns about the detection of a mutation of the SARS-CoV2 virus in the UK and is closely monitoring the situation in order to come up with appropriate prevention measures, according to Health Minister Nguyen Thanh Long.

VOV.VN - A further 17 people out of the 60 volunteers participating in the first phase of human trials to develop Nanocovax, a locally-produced novel coronavirus (COVID-19) vaccine, received their vaccine shots on December 22 at the Military Medical Academy.

VOV.VN - First human trials of Made-in-Vietnam for COVID-19 are set to begin at the Military Medical Academy in Hanoi on December 17.

VOV.VN - As many as 200 people have registered to participate in clinical trials for the locally-produced Nanocovax vaccine, with screening underway to select 60 people aged between 18 and 50 for the first phase, said Nguyen Ngo Quang, deputy director of the Department of Science, Technology and Training under the Ministry of Health on December 16.

VOV.VN - Local COVID-19 vaccine Nanocovax is anticipated to be put into use by the middle of 2021 following the conclusion of the evaluation results of the ongoing human trials and the facilitation of administrative procedures, said Do Minh Sy, director of Nanogen Pharmaceutical Biotechnology JSC, the domestic vaccine producer.

VOV.VN - Nanogen Pharmaceutical Biotechnology JSC have announced that it will develop a novel coronavirus (COVID-19) vaccine in the form of a nasal spray and eye drops in an effort to meet the various needs of different age groups nationwide.